Ordinary radiation uses X-ray beams. They pass all the way through the body. A beam leaves some of its dose on the way in, some at the tumor, and some on the way out. So healthy tissue behind the target is treated too. That becomes the thing that limits treatment when a tumor sits right against the spinal cord, the brainstem, the optic nerve, or the bowel. It is a particular worry in children. Their growing tissue is more easily harmed by stray radiation. They may also live for decades with whatever that radiation does. A proton beam behaves differently. Protons travel to a depth that the treatment plan sets. They release most of their energy there, and then they stop. Almost nothing carries on into the tissue beyond.
Shizuoka Cancer Center opened a proton therapy building of its own on the campus in October 2003. It holds two treatment rooms, each with a gantry that rotates around the patient. Patients have been treated there ever since. Proton planning sits inside the same Radiation and Proton Therapy Center that runs the hospital's ordinary radiation. That matters. Choosing between the two becomes a medical decision made here, not a referral out to a separate institution. The center takes more than 1,400 new patients a year.
What Japan's national insurance pays for has widened in steps, and this is the part that decides the bill. The first cancers covered were solid tumors in children. Bone and soft tissue tumors that had stayed in one place were covered too, in cases where surgery cannot cure. So were head and neck cancers, apart from squamous cell carcinoma of the mouth, the throat, and the voice box. Prostate cancer was covered when it had stayed in the gland or grown only into nearby tissue, with no spread to distant parts of the body. The 2022 revision added four more. One is liver cancer that starts in the liver cells and measures 4 cm or larger, called hepatocellular carcinoma. One is cancer of the bile ducts inside the liver, called intrahepatic cholangiocarcinoma. One is pancreatic cancer that has grown into the tissue around it. The last is bowel cancer that has come back in the same place after surgery. Each of those four is covered only where an operation cannot cure. In 2024 early lung cancer was added, at stages I through IIA, where surgery is not an option. Anything outside that list is billed as uncovered care. That changes the cost picture a great deal.
Protons are not the only radiation here. The center also runs linear accelerators for ordinary radiation given from outside the body. That includes intensity-modulated radiation therapy, which shapes the dose so it bends around organs that have to be spared. High-dose-rate brachytherapy works another way again. The radiation source is placed inside the body, right next to the tumor, and it is used for cancers of the female reproductive organs and of the lung. For prostate cancer the same idea is used with small seeds that stay in place permanently. Surgery is done with robot assistance and through an endoscope, a thin tube with a camera, as well as by open operation. Drug treatment includes molecular targeted agents, which are drugs aimed at one specific change inside the cancer cell. It also includes immune checkpoint inhibitors, which take the brakes off the patient's own immune system. The hospital puts unusual weight on the side of care that keeps treatment bearable day to day. It says it was the first cancer center in Japan to open a general advice service for patients and families, which it calls Yorozu Consultation. It later rebuilt its treatment unit into a Supportive Therapy Center, which it describes as the first of its kind in the country.